MANE - Veradermics, Inc

Insider Purchase by Suvretta Capital Management, LLC (Dir, 10%)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

2 months ago, Suvretta Capital Management, LLC, serving as Dir, 10% owner at Veradermics, Inc (MANE), purchased 282,674 shares at $37.30 per share, for a total transaction value of $10,542,478.00. Following this transaction, Suvretta Capital Management, LLC now holds 520,453 shares of MANE.

This purchase represents a 119.00% increase in Suvretta Capital Management, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, February 4, 2026 and publicly disclosed via SEC Form 4 filing on Monday, February 9, 2026, 5 days after the trade was made.

Veradermics, Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Suvretta Capital Management, LLC

Suvretta Capital Management, LLC

Dir, 10%

Suvretta Capital Management, LLC is a New York-based investment management firm founded in 2011 by Aaron Cowen, specializing in long/short equity strategies.[[1]](https://rocketreach.co/suvretta-capital-management-llc-profile_b7ce5552c15e34b1)[[2]](https://www.suvcap.com) The firm manages three primary strategies: a generalist long/short equity approach launched in September 2012 under Portfolio Manager Aaron Cowen, and two healthcare-focused strategies, Averill (started March 2020) and Averill Madison (launched November 2022), both led by Portfolio Manager Kishen Mehta.[[1]](https://rocketreach.co/suvretta-capital-management-llc-profile_b7ce5552c15e34b1)[[2]](https://www.suvcap.com) Headquartered at 540 Madison Avenue, 7th Floor, New York, NY, Suvretta Capital employs approximately 27-32 professionals and reported $13.8 million in revenue in 2024.[[1]](https://rocketreach.co/suvretta-capital-management-llc-profile_b7ce5552c15e34b1)[[3]](https://www.zoominfo.com/c/suvretta-capital-management-llc/374943810) As a registered investment adviser with the SEC (CRD #165153), the firm oversees significant assets, with recent 13F filings showing a portfolio market value of $3.32 billion as of June 30, 2025, including healthcare holdings like ARQT and ETNB.[[4]](https://whalewisdom.com/filer/suvretta-capital-management-llc)[[5]](https://adviserinfo.sec.gov/firm/summary/165153) Suvretta has acted as a corporate insider (Dir, 10%) in recent trades involving Benitec Biopharma Inc. (BNTC).[user_query]

View full insider profile →

Trade Price

$37.30

Quantity

282,674

Total Value

$10,542,478.00

Shares Owned

520,453

Trade Date

Wednesday, February 4, 2026

63 days ago

SEC Filing Date

Monday, February 9, 2026

Filed 5 days after trade

HEALTHCAREBIOTECHNOLOGY

About Veradermics, Inc

Company Overview

No company information available
View news mentioning MANE

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3843051

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime